No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 7.2x · 10Y median 18.1x · 6th percentile · as of Aug 25, 2026
Annualized revenue (TTM) · by quarter, last 24
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
The latest delayed quote for Doximity, Inc. (DOCS) stock was $24.74 as of Aug 26, 2026, 4:00 PM EDT, up 0.00% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -62.8% · 3-year avg +1.8%/yr · 5-year avg -23.1%/yr
Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States.
Medical - Healthcare Information Services · San Francisco, CA
How DOCS’s revenue breaks down across its reported segments in the latest reported fiscal year.
Next Earnings Date
Nov 5, 2026
71 days away
EPS Estimate
0.34
Revenue Est.
$170.57M
Last Quarter Results
EPS
$0.29
vs Estimate
$0.30
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1DOCS | $4.63B | $24.74 | +0.00% | -62.77% | -23.11% | N/A | N/A |
| 2TMDX | $3.19B | $92.22 | -1.47% | -18.60% | +26.74% | N/A | vs DOCS |
| 3HIMS | $6.65B | $29.83 | -6.05% | -34.24% | +31.88% | N/A | vs DOCS |
| 4XRAY | $2.19B | $10.93 | -0.36% | -21.79% | -27.44% | -14.53% | vs DOCS |
| 5OSCR | $8.10B | $31.24 | +1.00% | +85.18% | +18.73% | N/A | vs DOCS |
| 6TDOC | $1.15B | $6.33 | +2.26% | -19.31% | -46.76% | -9.44% | vs DOCS |
5.16
$156.62M
vs Estimate
$151.77M
Consensus Rating
Based on 18 analysts
Average Price Target
$29.78
+20.4% upside
Low
$18.00
Current
$24.74
High
$47.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.31 | $0.34 | $0.36 | 11 |
| Quarter ending Dec 2026 | $0.38 | $0.41 | $0.46 | 11 |
| Quarter ending Mar 2027 | $0.28 | $0.28 | $0.29 | 4 |
| Quarter ending Jun 2027 | $0.36 | $0.37 | $0.38 | 4 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $1.24 | $1.35 | $1.50 | 11 |
| FY 2028 | $1.40 | $1.55 | $1.77 | 10 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $170.24M | $170.57M | $171.20M | 11 |
| Quarter ending Dec 2026 | $189.41M | $194.29M | $200.55M | 11 |
| Quarter ending Mar 2027 | $152.72M | $155.06M | $157.87M | 5 |
| Quarter ending Jun 2027 | $163.53M | $166.03M | $169.04M | 5 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the next-fiscal-year consensus EPS estimate (the same value shown in the Key Metrics strip).
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2027 | $665.42M | $676.58M | $682.06M | 15 |
| FY 2028 | $704.30M | $720.93M | $742.21M | 13 |
